(800) 369-0899
(215) 569-4000

Contact Us Today



← Older posts Newer posts →

Role of MicroRNAs in a Mesothelioma Diagnosis

One of the main difficulties in treating malignant mesothelioma is its tendency to exhibit symptoms when the disease has progressed too far for effective treatment. Researchers worked to detect biomarkers by analyzing blood samples from patients who have been exposed to asbestos, but there is still much work to be done. MicroRNAs are tiny molecules » Read More

Mesothelioma Imaging System May Reduce Recurrence

A Massachusetts physician has started a clinical trial using a new imaging system that targets peritoneal mesothelioma, which is one of the most difficult cancers to treat. This disease starts in the abdominal cavity lining and can often spread to other parts of the body. Peritoneal mesothelioma differs from pleural mesothelioma, which affects the lungs. » Read More

The NIOSH Mesothelioma Registry

The first step toward creating a national mesothelioma registry has been taken by The National Institute for Occupational Safety and Health (NIOSH). The agency, which is part of the Centers for Disease Control and Prevention (CDC),¬†published a Request for Information in the Federal Register early last month. Its purpose is to seek input about ways » Read More

Risk for Mesothelioma Continues After Asbestos Exposure Ends

Leaving a job with potential asbestos exposure does not eliminate or decrease the possibility of developing mesothelioma. According to a recent study by U.S. and Italian researchers, those last exposed to asbestos years earlier are still at risk for developing mesothelioma, a form of cancer targeting the tissues lining the lungs, heart, testicles, stomach, and » Read More

← Older posts Newer posts →